seem to be responsible for local relapse and metastasis by inducing resistance against traditional drug therapy. Methods: In this study, we evaluated the immunohistochemical expression of OCT-4 and CD133…
questioned whether multi peptide immunotherapy targeting twenty antigens could be an approach to the development of refractory cancer immunotherapy in patients with good ECOG despite their prognosis. Methods: Forty…
initial direct acting antiviral agents increased viral clearance rates to 40%. Agents more recently developed have increased the rates of viral clearance to 95 to 100%. This initiated reports ... quarters of the…
antioxidant enzymes, glutathione peroxidase (GPx)-1 and -2, so called GPx1/2-DKO mice, develop ileocolitis around weaning. The hall-mark of pathology includes high crypt apoptosis, Paneth cell depletion ... impact than…
agents. The renowned addictive agents include drugs such as alcohol, nicotine, and other hard drugs. Individuals who are susceptible to addiction include those who are increasingly exposed to the addictive…
Rheumatoid arthritis is a common rheumatological disorder of unknown cause. The development of rheumatological disorders like rheumatoid arthritis depends on the interaction between genetic background and number of…
more active than the other clinical reverse-transcriptase inhibitor y 2’, 3’-dideoxy-nucleoside drugs, 3. very low toxic, 4. very long acting, 5. possible use for prophylaxis ... Merck & Co. as MK-8591. In the…
patient specific and disease-specific iPS cells offer great potential in regenerative medicine, in drug discovery and modelling disease processes in vitro. We report here the first generation of feeder ... ameliorated…
health care system and raise the question-does the policy maker need to develop treatment policy based on prioritization and sequencing for treatment lines to enhance patient's outcome including ... medians of both…
most promising nanomaterials with the capability of both detecting the cancerous cells and delivering drugs or small therapeutic molecules to these cells. Because of the unique structure, extremely high specific…
developed world. There are number of effective bio-macromolecule therapeutics available to treat patients with AMD but due to their susceptibility to biodegradation these drugs are required to be administered
fibers (gels) have been synthesized by solid phase peptide synthesizer and developed as nanocarriers of small molecular drugs. Results: These soft nanostructures were installed with target specific moieties like gastrin…
achieve the desired intra-liposomal drug concentration with the use of new loading method which would be highly desirable for the future development of promising CL formulation
modified and self-assembled into nanoparticles can be used as a drug carrier with wide development potential and has the advantage of slow/controlled drug release, which improves drug solubility ... stability against…
development of novel materials as scaffolds for cell culture has gained attention. The current challenge is to provide a scaffold that mimics natural tissues. We have synthetized at physiological temperature…
pathways during angiogenesis and other biological systems and therefore play important roles in physiological development as well as various patho-physiologies. Herein, we utilize a near-infrared fluorescent…
term of early diagnosis and targeted therapy. The utilization of nanotechnology for the development of new nano-carrier systems has the potential to offer improved chemotherapeutic delivery through increased solubility…
functional aspects matures over time, including immunological and metabolic properties. At every step of development, exogenous noxae and factors derived from maternal-fetal interaction can interfere and have…
infected animals prior to initiation of drug treatment requires the availability of sensitive and specific diagnostic tests. Recently, we describe the development of two heterologous sandwich assay formats (ELISA
control. Hence, plant based formulations may serve as an alternative source towards development of new drugs for treatment of malaria. The present study was aimed to validate the medicinal plant
strategies to develop the efficacy of drugs are required to treat the emerging infectious diseases and microbial resistance. A new effective strategy is to design drugs combined with metal nanoparticles
parasite, Plasmodium spp., through millions of years of coevolution with its natural hosts, has developed exquisitely sophisticated strategies to survive hostile environments in the blood and in mosquito tissues. Some…
ongoing globally challenge, mainly due to the increasing cases of resistance to current antimalarial drugs. In this context, we propose Antimicrobial Peptides (AMPs) isolated from different amphibian species, who have…